TrialInternational journal of hematology2009

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.

Hisashi Sakamaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.